MLN-3897 is able to inhibit osteoclastogenesis and OC activity by downregulating c-fos signaling which impairs multinucleation, Akt inhibition which reduces CLL3-induced MM cell migration, and the inhibition of the protective effects of OCs in MM survival (32). The gene discussed is AKT1; the disease is Miyoshi myopathy.